Analytical chemistry services, cGMP manufacturing and sterile fill services
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
135
NCT05301751
A Single Ascending Dose Cohort Study of AG-73305 in DME Patients
Phase: Phase 2
Role: Collaborator
Start: May 19, 2022
Completion: Dec 26, 2023
NCT06659549
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Start: Jan 10, 2025
Completion: May 30, 2027
Loading map...